Similar Search Results

Innovation under regulatory uncertainty : evidence from medical technology

Stern, Ariel D. - In: Journal of public economics 145 (2017), pp. 181-200

Persistent link: https://www.econbiz.de/10011745235

Who drives digital innovation? : evidence from the U.S. medical device industry

Foroughi, Cirrus; Stern, Ariel D. - 2019

Persistent link: https://www.econbiz.de/10012064942

In search of the missing hand of 'collaborative action' : evidence from the Indian medical device industry

Kale, Dinar; Wield, David V. - In: Innovation and development : RIAD 9 (2019) 1, pp. 1-23

Persistent link: https://www.econbiz.de/10012156951

Valuing Medical Innovation

Hemel, Daniel J.; Ouellette, Lisa Larrimore - 2022

.S. drug pricing system: Current law also provides weak incentives for medical innovation across wide areas, including vaccines … innovation not only slow the growth of U.S. life expectancy but also exacerbate racial disparities in health outcomes.High drug … prices and slow pharmaceutical progress are two facets of the same problem: a system that fails to reward medical innovation …

Persistent link: https://www.econbiz.de/10014078244

Marketing Pharmaceuticals and Medical Devices

Angelmar, Reinhard - 2012

This chapter reviews recent changes in the marketing of prescription pharmaceuticals and medical devices, It starts by …

Persistent link: https://www.econbiz.de/10013101323

Iqbal 'Plausibility' in Pharmaceutical and Medical Device Litigation

Janssen, William - 2014

This Article studied the actual effect of the United States Supreme Court's decision in Ashcroft v. Iqbal on the cohort of more than 264 federal pharmaceutical and medical device cases of every type, released from the day of the decision in Iqbal through August 31, 2010. The results of this...

Persistent link: https://www.econbiz.de/10013044566

Developing an Equivalent to the National Medicines Policy for Medical Devices

Faunce, Thomas Alured; Smith, Matthew W. - 2010

While Australia has enjoyed the benefits of a National Medicines Policy (NMP) for many years, there is no national equivalent policy for medical devices. This is despite an established medical device legal framework that spans multiple departments across the Australian Government. The existing...

Persistent link: https://www.econbiz.de/10014192511